Skip to content

Performance Indicators and Patient Experience in 7G and 10G Vacuum-assisted Excision of Probably Benign Breast Lesions

Performance Indicators and Patient Experience in 7G and 10G Vacuum-assisted Excision of Probably Benign Breast Lesions

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04911101
Enrollment
150
Registered
2021-06-02
Start date
2019-11-19
Completion date
2024-05-31
Last updated
2023-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Diseases

Keywords

Vacuum-assisted excision, Breast, Minimally invasive procedure, Needle size

Brief summary

The purpose of this study is to assess how the needle size 7G vs 10G affects performance indicators and patient experience in vacuum-assisted excision (VAE) of probably benign breast lesions

Detailed description

After being informed about the study and potential risks, all patients giving written informed consent will have a VAE procedure to remove their breast lesion and will be randomised to either 7G or 10G needle size. After completion of the procedure, the patients fill out a questionnaire to collect data on their experience. The radiologist performing the procedure fills out a form collecting procedural performance indicators.

Interventions

DEVICEExcision with 7G needle

Vacuum-assisted excision using a biopsy needle with two alternative dimensions

DEVICEExcision with 10G needle

Vacuum-assisted excision using a biopsy needle with two alternative dimensions

Sponsors

Stockholm South General Hospital
CollaboratorOTHER
Capio Sankt Görans Hospital
CollaboratorOTHER
Uppsala University Hospital
CollaboratorOTHER
Karolinska University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Biopsy-verified probably benign breast lesion less than 20 mm size * Biopsy-verified benign breast lesion less than 30 mm size * Screen-detected group of microcalcifications under 10 mm size

Exclusion criteria

* Age less than 18 years of age * Inability to understand the meaning of informed consent * Pregnancy * Breast-feeding

Design outcomes

Primary

MeasureTime frameDescription
Excision timeBaselineTime from excision start to excision stop - reported by radiologist
Pain assessed by NRS 2 weeks after baseline2 weeks after baselinePatient pain level during the experience - reported by patient in a 10-level NRS

Secondary

MeasureTime frameDescription
Self-reported number of patients who would recommend the procedure to others1 week after baselineWould the patient recommend the same procedure to others in same situation - reported by patient as yes or no
Self-reported satisfaction with cosmetic result assessed by a categorical scale1 week after baselineHow dissatisfied is the patient with the cosmetic result - reported by patient - using a categorical scale from not at all, somewhat, rather, very.
Number of patients with bleeding despite 10 minutes compressionBaselineBleeding despite 10 minutes compression - reported by radiologist
Remaining scar6 months after baselineYes = Any sign of prior trauma to the skin, No = Otherwise, Reported by radiologist as assessed by visual inspection
Pain assessed by NRS at baselineAt baselinePatient pain level during procedure - reported by patient in a 10-level NRS
Number of patients with self-reported occurrence of wound infection1 week after baselineOccurrence of wound infection - reported by patient as yes or no
Radicality assessment fractionsBaselineNumber of fractions possible to perform after the lesion has visually been removed - reported by radiologist

Countries

Sweden

Contacts

Primary ContactFredrik Strand, MD PhD
fredrik.strand@sll.se+46851770000
Backup ContactAthanasios Zouzos, MD
athanasios.zouzos@sll.se+46851770000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026